Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Clinical Colorectal Cancer
|
June 10, 2020
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan
Filippo Pietrantonio, Federica Morano, Monica Niger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2021
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Paolo Manca, Salvatore Corallo, Adele Busico, et al.
Journal of Hematology & Oncology
|
December 15, 2023
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2
Sara Pusceddu, Francesca Corti, Natalie Prinzi, et al.
Therapeutic Advances in Urology
|
October 28, 2021
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak
Melissa Bersanelli, Sebastiano Buti, Mimma Rizzo, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2022
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
Giovanni Fucà, Romain Cohen, Sara Lonardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2022
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O<sup>6</sup>-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial
Federica Morano, Alessandra Raimondi, Filippo Pagani, et al.
Molecular Oncology
|
May 27, 2022
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
Monica Niger, Federico Nichetti, Andrea Casadei-Gardini, et al.
JAMA Network Open
|
February 24, 2022
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
Sara Pusceddu, Natalie Prinzi, Salvatore Tafuto, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Clinical Colorectal Cancer
|
June 10, 2020
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan
Filippo Pietrantonio, Federica Morano, Monica Niger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2021
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Paolo Manca, Salvatore Corallo, Adele Busico, et al.
Journal of Hematology & Oncology
|
December 15, 2023
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2
Sara Pusceddu, Francesca Corti, Natalie Prinzi, et al.
Therapeutic Advances in Urology
|
October 28, 2021
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak
Melissa Bersanelli, Sebastiano Buti, Mimma Rizzo, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2022
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
Giovanni Fucà, Romain Cohen, Sara Lonardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2022
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O<sup>6</sup>-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial
Federica Morano, Alessandra Raimondi, Filippo Pagani, et al.
Molecular Oncology
|
May 27, 2022
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
Monica Niger, Federico Nichetti, Andrea Casadei-Gardini, et al.
JAMA Network Open
|
February 24, 2022
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
Sara Pusceddu, Natalie Prinzi, Salvatore Tafuto, et al.
Page
of 7